This has led to growing research interest in its metabolic regulatory effects, particularly in models examining obesity, glucose tolerance, and lipid homeostasis
FeelGood is a telehealth subscription platform that connects patients with licensed medical providers for evaluation and, when clinically appropriate, access to compounded GLP-1 weight loss medication
Rapamycin, an mTOR inhibitor, similarly promotes autophagy, attenuates pathological remodeling and is now in phase II clinical trials for HFpEF (Tables 1 and 2)
The same multi-system clinical breadth that makes GLP-1 Nobel-class is what makes it interesting to geroscience
Renal pathways excrete GLP-1 analogs, and clinicians do not adjust dosages for clients with mild renal or hepatic impairment (6)
Many patients feel fuller after eating much smaller portions, which can lead to modest weight loss and better eating habits for the future